Segment Information (Tables)

3 Months Ended

Dec. 31, 2020

Segment Reporting [Abstract]

Segment Revenue, Operating Income (Loss) and Depreciation and Amortization

Segment revenue, operating income (loss), and depreciation and amortization were as follows:

	Three Months Ended
	December 31,
(In thousands)	2020			2019
Revenue:
Medical Device	$	16,196		$	17,404
In Vitro Diagnostics		6,101			5,212
Total revenue	$	22,297		$	22,616
Operating income (loss):
Medical Device	$	(593	)	$	(423	)
In Vitro Diagnostics		3,220			2,599
Total segment operating income		2,627			2,176
Corporate		(2,534	)		(2,442	)
Total operating income (loss)	$	93		$	(266	)
Depreciation and amortization:
Medical Device	$	1,652		$	1,455
In Vitro Diagnostics		105			110
Corporate		103			239
Total depreciation and amortization	$	1,860		$	1,804